Written by Anthony Hardie, 91outcomes
(91outcomes.blogspot.com) -- A new European study shows that deficiency in Coenzyme Q10 (CoQ10) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in chronic fatigue syndrome/myalgic encepholitis (CFS/ME) due to cardiovascular disorder.
The study authors, from the Maes Clinic study (Maes Clinics, Antwerp, Belgium. email@example.com), state that their results suggest that taking CoQ10 supplementation would benefit people suffering from CFS/ME.
Furthermore, they suggest that, “lower CoQ10 is an independent predictor of chronic heart failure (CHF) and mortality due to CHF may explain previous reports that the mean age of ME/CFS patients dying from CHF is 25 years younger than the age of those dying from CHF in the general population.”
People taking drugs containing statins would benefit from taking CoQ10, because statins significantly decrease CoQ10 in the blood, according to the study authors.
Chronic Fatigue Syndrome is one of three presumptive conditions for VA service-connection for veterans of the 1991 Gulf War. Chronic fatigue symptoms have been near the top of most lists of scientific studies examining the health of Gulf War veterans.
The study was published in the Swedish medical journal Neuro Endocrinology Letters.